Schedule 13G ownership disclosure

MOONLAKE IMMUNOTHERAPEUTICS

Security class unavailable · CUSIP: 61559X104

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
17.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000929638-23-001056
Form type
SC 13G
Filer
Chen Bihua
CIK
CIK 1599214
Filed
Mar 31, 2023
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub